FDA UNTITLED_LETTER - The Compounding Pharmacy of Beverly Hills - September 17, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns The Compounding Pharmacy of Beverly Hills, with an inspection on September 17, 2020, covering drugs.

Company: The Compounding Pharmacy of Beverly Hills
Inspection Date: September 17, 2020
Product Type: Drugs
Person: Steven E. Porter (Program Division Director)

Open in Dashboard

ID · a9777c34-3062-4d64-9ae7-3a9c83ff0587

Violation Codes9

FD&C Act 501(a)(2)(B)21 U.S.C. 331(k)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)FD&C Act 505FD&C Act 502(f)(1)21 U.S.C. 355(a)21 U.S.C. 353a21 CFR 201.115

Full citation text and observation details available on the Dashboard.